September 17, 2022 — Medtronic today announced findings from its Pathological Study of Hypo-Attenuated Leaflet Thickening (HALT) in Self-Expanding Transcatheter Aortic Valves, as part of the CoreValve Evolut Program. The study is the first to compare microCT and histology findings of valve leaflet thickening, the results of which may provide clinical insights for long-term durability of transcatheter aortic valves (TAVs) and treatment of HALT.

September 16, 2022 — CathWorks announced today the schedule of key events for the company during Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics (TCT) 2022 conference taking place September 16 to 19 at the Boston Convention and Exhibition Center in Boston, Massachusetts. 

September 15, 2022 — Today, aortic stenosis (AS) is one of the most common and serious valve disease problems [1]. It narrows the aortic valve opening and restricts the blood flow to the heart, making the heart work harder and potentially causing symptoms including chest pain, shortness of breath and fatigue. Left untreated, severe aortic valve stenosis can lead to death.

September 15, 2022 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its latest innovations and cardiology solutions designed to strengthen clinical confidence, build efficiency throughout the care pathway and improve cardiac care experiences at the Transcatheter Cardiovascular Therapeutics

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now